Robert E Claypoole is President and CEO of Bioventus Inc.. Currently has a direct ownership of 116,997 shares of BVS, which is worth approximately $859,927. The most recent transaction as insider was on Jan 09, 2026, when has been sold 41,717 shares (Class A Common Stock) at a price of $8.03 per share, resulting in proceeds of $334,987. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K
80.1% 3M change
80.1% 12M change
Total Value Held $859,927

Robert E Claypoole Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2026
SELL
Payment of exercise price or tax liability
$334,987 $8.03 p/Share
41,717 Reduced 26.28%
116,997 Class A Common Stock
Jan 09 2026
BUY
Exercise of conversion of derivative security
-
93,750 Added 37.13%
158,714 Class A Common Stock
Jan 13 2025
SELL
Open market or private sale
$261,952 $9.1 p/Share
28,786 Reduced 30.71%
64,964 Class A Common Stock
Jan 10 2025
BUY
Exercise of conversion of derivative security
-
93,750 Added 50.0%
93,750 Class A Common Stock
REC

Robert E Claypoole

President and CEO
Durham, NC

Track Institutional and Insider Activities on BVS

Follow Bioventus Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if

News

Receive news related to Bioventus Inc.

Track Activities on BVS